nodes	percent_of_prediction	percent_of_DWPC	metapath
Thioridazine—Promazine—Tamoxifen—pancreatic cancer	0.189	1	CrCrCtD
Thioridazine—CYP2E1—Dacarbazine—pancreatic cancer	0.0662	0.124	CbGbCtD
Thioridazine—KCNH2—Sunitinib—pancreatic cancer	0.0597	0.112	CbGbCtD
Thioridazine—CYP2E1—Tamoxifen—pancreatic cancer	0.0526	0.0984	CbGbCtD
Thioridazine—CYP2C8—Tamoxifen—pancreatic cancer	0.0393	0.0735	CbGbCtD
Thioridazine—CYP1A2—Dacarbazine—pancreatic cancer	0.0383	0.0715	CbGbCtD
Thioridazine—CYP2C8—Erlotinib—pancreatic cancer	0.0334	0.0625	CbGbCtD
Thioridazine—CYP2C19—Tamoxifen—pancreatic cancer	0.033	0.0617	CbGbCtD
Thioridazine—CYP1A2—Tamoxifen—pancreatic cancer	0.0304	0.0569	CbGbCtD
Thioridazine—CYP2C8—Fluorouracil—pancreatic cancer	0.029	0.0542	CbGbCtD
Thioridazine—CYP2C9—Tamoxifen—pancreatic cancer	0.0274	0.0513	CbGbCtD
Thioridazine—CYP1A2—Erlotinib—pancreatic cancer	0.0259	0.0484	CbGbCtD
Thioridazine—CYP2D6—Tamoxifen—pancreatic cancer	0.0251	0.0469	CbGbCtD
Thioridazine—CYP1A2—Fluorouracil—pancreatic cancer	0.0224	0.0419	CbGbCtD
Thioridazine—CYP2D6—Erlotinib—pancreatic cancer	0.0213	0.0399	CbGbCtD
Thioridazine—CYP2C9—Fluorouracil—pancreatic cancer	0.0202	0.0378	CbGbCtD
Thioridazine—CYP2D6—Doxorubicin—pancreatic cancer	0.0105	0.0197	CbGbCtD
Thioridazine—HTR7—enteric nervous system—pancreatic cancer	0.00404	0.457	CbGeAlD
Thioridazine—HTR2A—enteric nervous system—pancreatic cancer	0.00252	0.285	CbGeAlD
Thioridazine—Eruption—Doxorubicin—pancreatic cancer	0.000722	0.00565	CcSEcCtD
Thioridazine—Oedema peripheral—Tamoxifen—pancreatic cancer	0.000722	0.00565	CcSEcCtD
Thioridazine—Cardiac arrest—Irinotecan—pancreatic cancer	0.000711	0.00556	CcSEcCtD
Thioridazine—Cardiac arrest—Fluorouracil—pancreatic cancer	0.000681	0.00533	CcSEcCtD
Thioridazine—Arrhythmia—Tamoxifen—pancreatic cancer	0.000655	0.00512	CcSEcCtD
Thioridazine—Ventricular arrhythmia—Epirubicin—pancreatic cancer	0.000649	0.00508	CcSEcCtD
Thioridazine—Arrhythmia—Erlotinib—pancreatic cancer	0.000648	0.00507	CcSEcCtD
Thioridazine—Erythema—Tamoxifen—pancreatic cancer	0.000638	0.00499	CcSEcCtD
Thioridazine—Mental disorder—Erlotinib—pancreatic cancer	0.000635	0.00497	CcSEcCtD
Thioridazine—Erythema—Erlotinib—pancreatic cancer	0.000631	0.00494	CcSEcCtD
Thioridazine—Sweating increased—Irinotecan—pancreatic cancer	0.000629	0.00492	CcSEcCtD
Thioridazine—Oedema peripheral—Sunitinib—pancreatic cancer	0.000618	0.00484	CcSEcCtD
Thioridazine—Eosinophilia—Fluorouracil—pancreatic cancer	0.000613	0.00479	CcSEcCtD
Thioridazine—Ventricular arrhythmia—Doxorubicin—pancreatic cancer	0.0006	0.0047	CcSEcCtD
Thioridazine—Pancytopenia—Gemcitabine—pancreatic cancer	0.000598	0.00468	CcSEcCtD
Thioridazine—Anaemia—Tamoxifen—pancreatic cancer	0.00059	0.00461	CcSEcCtD
Thioridazine—Pancytopenia—Fluorouracil—pancreatic cancer	0.000588	0.0046	CcSEcCtD
Thioridazine—Angioedema—Tamoxifen—pancreatic cancer	0.000583	0.00456	CcSEcCtD
Thioridazine—Blood disorder—Epirubicin—pancreatic cancer	0.000575	0.0045	CcSEcCtD
Thioridazine—Leukopenia—Tamoxifen—pancreatic cancer	0.000571	0.00447	CcSEcCtD
Thioridazine—Photosensitivity reaction—Fluorouracil—pancreatic cancer	0.000565	0.00442	CcSEcCtD
Thioridazine—Jaundice—Irinotecan—pancreatic cancer	0.000562	0.00439	CcSEcCtD
Thioridazine—Arrhythmia—Sunitinib—pancreatic cancer	0.000561	0.00439	CcSEcCtD
Thioridazine—Mental disorder—Sunitinib—pancreatic cancer	0.00055	0.0043	CcSEcCtD
Thioridazine—Erythema—Sunitinib—pancreatic cancer	0.000547	0.00428	CcSEcCtD
Thioridazine—Amenorrhoea—Epirubicin—pancreatic cancer	0.000546	0.00428	CcSEcCtD
Thioridazine—Blood disorder—Doxorubicin—pancreatic cancer	0.000532	0.00416	CcSEcCtD
Thioridazine—Lethargy—Docetaxel—pancreatic cancer	0.000527	0.00413	CcSEcCtD
Thioridazine—Agranulocytosis—Gemcitabine—pancreatic cancer	0.000524	0.0041	CcSEcCtD
Thioridazine—Oedema—Tamoxifen—pancreatic cancer	0.000521	0.00407	CcSEcCtD
Thioridazine—Oedema—Erlotinib—pancreatic cancer	0.000515	0.00403	CcSEcCtD
Thioridazine—Agranulocytosis—Fluorouracil—pancreatic cancer	0.000515	0.00403	CcSEcCtD
Thioridazine—Thrombocytopenia—Tamoxifen—pancreatic cancer	0.00051	0.00399	CcSEcCtD
Thioridazine—Amenorrhoea—Doxorubicin—pancreatic cancer	0.000506	0.00396	CcSEcCtD
Thioridazine—Anaemia—Sunitinib—pancreatic cancer	0.000505	0.00395	CcSEcCtD
Thioridazine—Thrombocytopenia—Erlotinib—pancreatic cancer	0.000504	0.00395	CcSEcCtD
Thioridazine—Hyperhidrosis—Tamoxifen—pancreatic cancer	0.000503	0.00394	CcSEcCtD
Thioridazine—Angioedema—Sunitinib—pancreatic cancer	0.000499	0.00391	CcSEcCtD
Thioridazine—Anorexia—Tamoxifen—pancreatic cancer	0.000496	0.00388	CcSEcCtD
Thioridazine—Oedema peripheral—Gemcitabine—pancreatic cancer	0.000496	0.00388	CcSEcCtD
Thioridazine—Anorexia—Erlotinib—pancreatic cancer	0.000491	0.00384	CcSEcCtD
Thioridazine—Leukopenia—Sunitinib—pancreatic cancer	0.000489	0.00383	CcSEcCtD
Thioridazine—Ventricular tachycardia—Epirubicin—pancreatic cancer	0.00048	0.00376	CcSEcCtD
Thioridazine—Abnormal dreams—Epirubicin—pancreatic cancer	0.000475	0.00371	CcSEcCtD
Thioridazine—Dermatitis contact—Epirubicin—pancreatic cancer	0.000475	0.00371	CcSEcCtD
Thioridazine—Arrhythmia—Irinotecan—pancreatic cancer	0.000462	0.00361	CcSEcCtD
Thioridazine—Decreased appetite—Tamoxifen—pancreatic cancer	0.000453	0.00354	CcSEcCtD
Thioridazine—Aplastic anaemia—Epirubicin—pancreatic cancer	0.000451	0.00353	CcSEcCtD
Thioridazine—Arrhythmia—Gemcitabine—pancreatic cancer	0.00045	0.00352	CcSEcCtD
Thioridazine—Decreased appetite—Erlotinib—pancreatic cancer	0.000448	0.0035	CcSEcCtD
Thioridazine—Oedema—Sunitinib—pancreatic cancer	0.000446	0.00349	CcSEcCtD
Thioridazine—Constipation—Tamoxifen—pancreatic cancer	0.000445	0.00348	CcSEcCtD
Thioridazine—Ventricular tachycardia—Doxorubicin—pancreatic cancer	0.000444	0.00348	CcSEcCtD
Thioridazine—Arrhythmia—Fluorouracil—pancreatic cancer	0.000442	0.00346	CcSEcCtD
Thioridazine—Constipation—Erlotinib—pancreatic cancer	0.000441	0.00345	CcSEcCtD
Thioridazine—Dermatitis contact—Doxorubicin—pancreatic cancer	0.000439	0.00344	CcSEcCtD
Thioridazine—Abnormal dreams—Doxorubicin—pancreatic cancer	0.000439	0.00344	CcSEcCtD
Thioridazine—Erythema—Gemcitabine—pancreatic cancer	0.000439	0.00343	CcSEcCtD
Thioridazine—Thrombocytopenia—Sunitinib—pancreatic cancer	0.000437	0.00342	CcSEcCtD
Thioridazine—Erythema—Fluorouracil—pancreatic cancer	0.000431	0.00337	CcSEcCtD
Thioridazine—Anorexia—Sunitinib—pancreatic cancer	0.000425	0.00333	CcSEcCtD
Thioridazine—Pancytopenia—Docetaxel—pancreatic cancer	0.000424	0.00332	CcSEcCtD
Thioridazine—Aplastic anaemia—Doxorubicin—pancreatic cancer	0.000417	0.00326	CcSEcCtD
Thioridazine—Anaemia—Irinotecan—pancreatic cancer	0.000416	0.00326	CcSEcCtD
Thioridazine—Body temperature increased—Erlotinib—pancreatic cancer	0.000407	0.00319	CcSEcCtD
Thioridazine—Weight increased—Docetaxel—pancreatic cancer	0.000406	0.00318	CcSEcCtD
Thioridazine—Vision blurred—Fluorouracil—pancreatic cancer	0.000406	0.00318	CcSEcCtD
Thioridazine—Anaemia—Gemcitabine—pancreatic cancer	0.000405	0.00317	CcSEcCtD
Thioridazine—Leukopenia—Irinotecan—pancreatic cancer	0.000403	0.00315	CcSEcCtD
Thioridazine—Anaemia—Fluorouracil—pancreatic cancer	0.000399	0.00312	CcSEcCtD
Thioridazine—Photosensitivity—Epirubicin—pancreatic cancer	0.000397	0.00311	CcSEcCtD
Thioridazine—Leukopenia—Gemcitabine—pancreatic cancer	0.000393	0.00307	CcSEcCtD
Thioridazine—Jaundice—Docetaxel—pancreatic cancer	0.000388	0.00304	CcSEcCtD
Thioridazine—Decreased appetite—Sunitinib—pancreatic cancer	0.000388	0.00303	CcSEcCtD
Thioridazine—Leukopenia—Fluorouracil—pancreatic cancer	0.000386	0.00302	CcSEcCtD
Thioridazine—Hypersensitivity—Tamoxifen—pancreatic cancer	0.000384	0.003	CcSEcCtD
Thioridazine—Constipation—Sunitinib—pancreatic cancer	0.000381	0.00298	CcSEcCtD
Thioridazine—Agranulocytosis—Docetaxel—pancreatic cancer	0.000372	0.00291	CcSEcCtD
Thioridazine—Confusional state—Irinotecan—pancreatic cancer	0.00037	0.0029	CcSEcCtD
Thioridazine—Dermatitis exfoliative—Epirubicin—pancreatic cancer	0.000369	0.00289	CcSEcCtD
Thioridazine—Oedema—Irinotecan—pancreatic cancer	0.000367	0.00287	CcSEcCtD
Thioridazine—Photosensitivity—Doxorubicin—pancreatic cancer	0.000367	0.00287	CcSEcCtD
Thioridazine—KCNH2—islet of Langerhans—pancreatic cancer	0.00036	0.0407	CbGeAlD
Thioridazine—Thrombocytopenia—Irinotecan—pancreatic cancer	0.00036	0.00281	CcSEcCtD
Thioridazine—Oedema—Gemcitabine—pancreatic cancer	0.000358	0.0028	CcSEcCtD
Thioridazine—Diarrhoea—Tamoxifen—pancreatic cancer	0.000356	0.00279	CcSEcCtD
Thioridazine—Lethargy—Epirubicin—pancreatic cancer	0.000356	0.00278	CcSEcCtD
Thioridazine—Hyperhidrosis—Irinotecan—pancreatic cancer	0.000355	0.00278	CcSEcCtD
Thioridazine—Confusional state—Fluorouracil—pancreatic cancer	0.000355	0.00278	CcSEcCtD
Thioridazine—Body temperature increased—Sunitinib—pancreatic cancer	0.000353	0.00276	CcSEcCtD
Thioridazine—Diarrhoea—Erlotinib—pancreatic cancer	0.000353	0.00276	CcSEcCtD
Thioridazine—Oedema peripheral—Docetaxel—pancreatic cancer	0.000352	0.00276	CcSEcCtD
Thioridazine—Oedema—Fluorouracil—pancreatic cancer	0.000352	0.00275	CcSEcCtD
Thioridazine—Thrombocytopenia—Gemcitabine—pancreatic cancer	0.00035	0.00274	CcSEcCtD
Thioridazine—Anorexia—Irinotecan—pancreatic cancer	0.00035	0.00274	CcSEcCtD
Thioridazine—Hyperhidrosis—Gemcitabine—pancreatic cancer	0.000346	0.00271	CcSEcCtD
Thioridazine—Thrombocytopenia—Fluorouracil—pancreatic cancer	0.000345	0.0027	CcSEcCtD
Thioridazine—Tachycardia—Fluorouracil—pancreatic cancer	0.000343	0.00269	CcSEcCtD
Thioridazine—Hypotension—Irinotecan—pancreatic cancer	0.000343	0.00269	CcSEcCtD
Thioridazine—Dermatitis exfoliative—Doxorubicin—pancreatic cancer	0.000342	0.00267	CcSEcCtD
Thioridazine—Anorexia—Gemcitabine—pancreatic cancer	0.000341	0.00267	CcSEcCtD
Thioridazine—Anorexia—Fluorouracil—pancreatic cancer	0.000335	0.00262	CcSEcCtD
Thioridazine—Hypotension—Gemcitabine—pancreatic cancer	0.000334	0.00262	CcSEcCtD
Thioridazine—Cardiac arrest—Epirubicin—pancreatic cancer	0.000331	0.00259	CcSEcCtD
Thioridazine—Vomiting—Tamoxifen—pancreatic cancer	0.000331	0.00259	CcSEcCtD
Thioridazine—Lethargy—Doxorubicin—pancreatic cancer	0.000329	0.00258	CcSEcCtD
Thioridazine—Hypotension—Fluorouracil—pancreatic cancer	0.000329	0.00257	CcSEcCtD
Thioridazine—Hypersensitivity—Sunitinib—pancreatic cancer	0.000329	0.00257	CcSEcCtD
Thioridazine—Rash—Tamoxifen—pancreatic cancer	0.000328	0.00257	CcSEcCtD
Thioridazine—Dermatitis—Tamoxifen—pancreatic cancer	0.000328	0.00257	CcSEcCtD
Thioridazine—Vomiting—Erlotinib—pancreatic cancer	0.000328	0.00256	CcSEcCtD
Thioridazine—Somnolence—Irinotecan—pancreatic cancer	0.000327	0.00256	CcSEcCtD
Thioridazine—Headache—Tamoxifen—pancreatic cancer	0.000326	0.00255	CcSEcCtD
Thioridazine—Rash—Erlotinib—pancreatic cancer	0.000325	0.00254	CcSEcCtD
Thioridazine—Dermatitis—Erlotinib—pancreatic cancer	0.000325	0.00254	CcSEcCtD
Thioridazine—Headache—Erlotinib—pancreatic cancer	0.000323	0.00253	CcSEcCtD
Thioridazine—Decreased appetite—Irinotecan—pancreatic cancer	0.000319	0.0025	CcSEcCtD
Thioridazine—Arrhythmia—Docetaxel—pancreatic cancer	0.000319	0.0025	CcSEcCtD
Thioridazine—Somnolence—Gemcitabine—pancreatic cancer	0.000318	0.00249	CcSEcCtD
Thioridazine—Constipation—Irinotecan—pancreatic cancer	0.000314	0.00246	CcSEcCtD
Thioridazine—Mental disorder—Docetaxel—pancreatic cancer	0.000313	0.00245	CcSEcCtD
Thioridazine—Somnolence—Fluorouracil—pancreatic cancer	0.000313	0.00245	CcSEcCtD
Thioridazine—Erythema—Docetaxel—pancreatic cancer	0.000311	0.00243	CcSEcCtD
Thioridazine—Decreased appetite—Gemcitabine—pancreatic cancer	0.000311	0.00243	CcSEcCtD
Thioridazine—Nausea—Tamoxifen—pancreatic cancer	0.000309	0.00242	CcSEcCtD
Thioridazine—Cardiac arrest—Doxorubicin—pancreatic cancer	0.000307	0.0024	CcSEcCtD
Thioridazine—Constipation—Gemcitabine—pancreatic cancer	0.000306	0.00239	CcSEcCtD
Thioridazine—Nausea—Erlotinib—pancreatic cancer	0.000306	0.00239	CcSEcCtD
Thioridazine—Decreased appetite—Fluorouracil—pancreatic cancer	0.000306	0.00239	CcSEcCtD
Thioridazine—Diarrhoea—Sunitinib—pancreatic cancer	0.000305	0.00239	CcSEcCtD
Thioridazine—Feeling abnormal—Irinotecan—pancreatic cancer	0.000303	0.00237	CcSEcCtD
Thioridazine—Asthma—Epirubicin—pancreatic cancer	0.000301	0.00236	CcSEcCtD
Thioridazine—Eosinophilia—Epirubicin—pancreatic cancer	0.000298	0.00233	CcSEcCtD
Thioridazine—Feeling abnormal—Gemcitabine—pancreatic cancer	0.000295	0.00231	CcSEcCtD
Thioridazine—Body temperature increased—Irinotecan—pancreatic cancer	0.00029	0.00227	CcSEcCtD
Thioridazine—Feeling abnormal—Fluorouracil—pancreatic cancer	0.00029	0.00227	CcSEcCtD
Thioridazine—Anaemia—Docetaxel—pancreatic cancer	0.000288	0.00225	CcSEcCtD
Thioridazine—Pancytopenia—Epirubicin—pancreatic cancer	0.000286	0.00224	CcSEcCtD
Thioridazine—Vomiting—Sunitinib—pancreatic cancer	0.000284	0.00222	CcSEcCtD
Thioridazine—ADRA2A—islet of Langerhans—pancreatic cancer	0.000283	0.032	CbGeAlD
Thioridazine—Body temperature increased—Gemcitabine—pancreatic cancer	0.000283	0.00221	CcSEcCtD
Thioridazine—Rash—Sunitinib—pancreatic cancer	0.000281	0.0022	CcSEcCtD
Thioridazine—Dermatitis—Sunitinib—pancreatic cancer	0.000281	0.0022	CcSEcCtD
Thioridazine—Headache—Sunitinib—pancreatic cancer	0.000279	0.00219	CcSEcCtD
Thioridazine—Asthma—Doxorubicin—pancreatic cancer	0.000279	0.00218	CcSEcCtD
Thioridazine—Leukopenia—Docetaxel—pancreatic cancer	0.000279	0.00218	CcSEcCtD
Thioridazine—Body temperature increased—Fluorouracil—pancreatic cancer	0.000278	0.00218	CcSEcCtD
Thioridazine—Eosinophilia—Doxorubicin—pancreatic cancer	0.000276	0.00216	CcSEcCtD
Thioridazine—Photosensitivity reaction—Epirubicin—pancreatic cancer	0.000275	0.00215	CcSEcCtD
Thioridazine—Weight increased—Epirubicin—pancreatic cancer	0.000274	0.00215	CcSEcCtD
Thioridazine—Hypersensitivity—Irinotecan—pancreatic cancer	0.000271	0.00212	CcSEcCtD
Thioridazine—Drowsiness—Epirubicin—pancreatic cancer	0.000269	0.0021	CcSEcCtD
Thioridazine—Nausea—Sunitinib—pancreatic cancer	0.000265	0.00207	CcSEcCtD
Thioridazine—Pancytopenia—Doxorubicin—pancreatic cancer	0.000265	0.00207	CcSEcCtD
Thioridazine—Jaundice—Epirubicin—pancreatic cancer	0.000262	0.00205	CcSEcCtD
Thioridazine—Hypersensitivity—Fluorouracil—pancreatic cancer	0.000259	0.00203	CcSEcCtD
Thioridazine—Confusional state—Docetaxel—pancreatic cancer	0.000256	0.002	CcSEcCtD
Thioridazine—Photosensitivity reaction—Doxorubicin—pancreatic cancer	0.000254	0.00199	CcSEcCtD
Thioridazine—Oedema—Docetaxel—pancreatic cancer	0.000254	0.00199	CcSEcCtD
Thioridazine—Weight increased—Doxorubicin—pancreatic cancer	0.000254	0.00198	CcSEcCtD
Thioridazine—Diarrhoea—Irinotecan—pancreatic cancer	0.000251	0.00197	CcSEcCtD
Thioridazine—Agranulocytosis—Epirubicin—pancreatic cancer	0.000251	0.00196	CcSEcCtD
Thioridazine—Thrombocytopenia—Docetaxel—pancreatic cancer	0.000249	0.00195	CcSEcCtD
Thioridazine—Drowsiness—Doxorubicin—pancreatic cancer	0.000249	0.00194	CcSEcCtD
Thioridazine—Tachycardia—Docetaxel—pancreatic cancer	0.000248	0.00194	CcSEcCtD
Thioridazine—Diarrhoea—Gemcitabine—pancreatic cancer	0.000245	0.00192	CcSEcCtD
Thioridazine—Jaundice—Doxorubicin—pancreatic cancer	0.000242	0.0019	CcSEcCtD
Thioridazine—Anorexia—Docetaxel—pancreatic cancer	0.000242	0.00189	CcSEcCtD
Thioridazine—Diarrhoea—Fluorouracil—pancreatic cancer	0.000241	0.00188	CcSEcCtD
Thioridazine—Oedema peripheral—Epirubicin—pancreatic cancer	0.000238	0.00186	CcSEcCtD
Thioridazine—Hypotension—Docetaxel—pancreatic cancer	0.000237	0.00186	CcSEcCtD
Thioridazine—Vomiting—Irinotecan—pancreatic cancer	0.000234	0.00183	CcSEcCtD
Thioridazine—HTR7—digestive system—pancreatic cancer	0.000232	0.0262	CbGeAlD
Thioridazine—Agranulocytosis—Doxorubicin—pancreatic cancer	0.000232	0.00181	CcSEcCtD
Thioridazine—Rash—Irinotecan—pancreatic cancer	0.000232	0.00181	CcSEcCtD
Thioridazine—Dermatitis—Irinotecan—pancreatic cancer	0.000231	0.00181	CcSEcCtD
Thioridazine—Headache—Irinotecan—pancreatic cancer	0.00023	0.0018	CcSEcCtD
Thioridazine—Vomiting—Gemcitabine—pancreatic cancer	0.000228	0.00178	CcSEcCtD
Thioridazine—CYP2C19—digestive system—pancreatic cancer	0.000227	0.0256	CbGeAlD
Thioridazine—Somnolence—Docetaxel—pancreatic cancer	0.000226	0.00177	CcSEcCtD
Thioridazine—Rash—Gemcitabine—pancreatic cancer	0.000226	0.00177	CcSEcCtD
Thioridazine—Dermatitis—Gemcitabine—pancreatic cancer	0.000225	0.00176	CcSEcCtD
Thioridazine—Headache—Gemcitabine—pancreatic cancer	0.000224	0.00175	CcSEcCtD
Thioridazine—Vomiting—Fluorouracil—pancreatic cancer	0.000224	0.00175	CcSEcCtD
Thioridazine—Rash—Fluorouracil—pancreatic cancer	0.000222	0.00174	CcSEcCtD
Thioridazine—Dermatitis—Fluorouracil—pancreatic cancer	0.000222	0.00173	CcSEcCtD
Thioridazine—Decreased appetite—Docetaxel—pancreatic cancer	0.000221	0.00173	CcSEcCtD
Thioridazine—Headache—Fluorouracil—pancreatic cancer	0.00022	0.00172	CcSEcCtD
Thioridazine—Oedema peripheral—Doxorubicin—pancreatic cancer	0.00022	0.00172	CcSEcCtD
Thioridazine—Nausea—Irinotecan—pancreatic cancer	0.000218	0.00171	CcSEcCtD
Thioridazine—Constipation—Docetaxel—pancreatic cancer	0.000217	0.0017	CcSEcCtD
Thioridazine—Arrhythmia—Epirubicin—pancreatic cancer	0.000215	0.00169	CcSEcCtD
Thioridazine—Nausea—Gemcitabine—pancreatic cancer	0.000213	0.00166	CcSEcCtD
Thioridazine—Mental disorder—Epirubicin—pancreatic cancer	0.000211	0.00165	CcSEcCtD
Thioridazine—Erythema—Epirubicin—pancreatic cancer	0.00021	0.00164	CcSEcCtD
Thioridazine—Feeling abnormal—Docetaxel—pancreatic cancer	0.000209	0.00164	CcSEcCtD
Thioridazine—Nausea—Fluorouracil—pancreatic cancer	0.000209	0.00164	CcSEcCtD
Thioridazine—Body temperature increased—Docetaxel—pancreatic cancer	0.000201	0.00157	CcSEcCtD
Thioridazine—Arrhythmia—Doxorubicin—pancreatic cancer	0.000199	0.00156	CcSEcCtD
Thioridazine—ADRA2A—pancreas—pancreatic cancer	0.000199	0.0225	CbGeAlD
Thioridazine—Vision blurred—Epirubicin—pancreatic cancer	0.000198	0.00155	CcSEcCtD
Thioridazine—Mental disorder—Doxorubicin—pancreatic cancer	0.000195	0.00153	CcSEcCtD
Thioridazine—Erythema—Doxorubicin—pancreatic cancer	0.000194	0.00152	CcSEcCtD
Thioridazine—Anaemia—Epirubicin—pancreatic cancer	0.000194	0.00152	CcSEcCtD
Thioridazine—Agitation—Epirubicin—pancreatic cancer	0.000193	0.00151	CcSEcCtD
Thioridazine—Leukopenia—Epirubicin—pancreatic cancer	0.000188	0.00147	CcSEcCtD
Thioridazine—Hypersensitivity—Docetaxel—pancreatic cancer	0.000187	0.00146	CcSEcCtD
Thioridazine—CYP1A2—digestive system—pancreatic cancer	0.000185	0.0209	CbGeAlD
Thioridazine—Vision blurred—Doxorubicin—pancreatic cancer	0.000183	0.00143	CcSEcCtD
Thioridazine—Anaemia—Doxorubicin—pancreatic cancer	0.00018	0.0014	CcSEcCtD
Thioridazine—Agitation—Doxorubicin—pancreatic cancer	0.000178	0.0014	CcSEcCtD
Thioridazine—CYP2C9—digestive system—pancreatic cancer	0.000176	0.0199	CbGeAlD
Thioridazine—Leukopenia—Doxorubicin—pancreatic cancer	0.000174	0.00136	CcSEcCtD
Thioridazine—Diarrhoea—Docetaxel—pancreatic cancer	0.000174	0.00136	CcSEcCtD
Thioridazine—HRH1—digestive system—pancreatic cancer	0.000173	0.0196	CbGeAlD
Thioridazine—Confusional state—Epirubicin—pancreatic cancer	0.000173	0.00135	CcSEcCtD
Thioridazine—Oedema—Epirubicin—pancreatic cancer	0.000171	0.00134	CcSEcCtD
Thioridazine—Thrombocytopenia—Epirubicin—pancreatic cancer	0.000168	0.00131	CcSEcCtD
Thioridazine—Tachycardia—Epirubicin—pancreatic cancer	0.000167	0.00131	CcSEcCtD
Thioridazine—CYP2E1—digestive system—pancreatic cancer	0.000166	0.0188	CbGeAlD
Thioridazine—Hyperhidrosis—Epirubicin—pancreatic cancer	0.000166	0.0013	CcSEcCtD
Thioridazine—Anorexia—Epirubicin—pancreatic cancer	0.000163	0.00128	CcSEcCtD
Thioridazine—Vomiting—Docetaxel—pancreatic cancer	0.000161	0.00126	CcSEcCtD
Thioridazine—Rash—Docetaxel—pancreatic cancer	0.00016	0.00125	CcSEcCtD
Thioridazine—Hypotension—Epirubicin—pancreatic cancer	0.00016	0.00125	CcSEcCtD
Thioridazine—Dermatitis—Docetaxel—pancreatic cancer	0.00016	0.00125	CcSEcCtD
Thioridazine—Confusional state—Doxorubicin—pancreatic cancer	0.00016	0.00125	CcSEcCtD
Thioridazine—Headache—Docetaxel—pancreatic cancer	0.000159	0.00124	CcSEcCtD
Thioridazine—Oedema—Doxorubicin—pancreatic cancer	0.000159	0.00124	CcSEcCtD
Thioridazine—Thrombocytopenia—Doxorubicin—pancreatic cancer	0.000155	0.00121	CcSEcCtD
Thioridazine—Tachycardia—Doxorubicin—pancreatic cancer	0.000155	0.00121	CcSEcCtD
Thioridazine—Hyperhidrosis—Doxorubicin—pancreatic cancer	0.000153	0.0012	CcSEcCtD
Thioridazine—Somnolence—Epirubicin—pancreatic cancer	0.000152	0.00119	CcSEcCtD
Thioridazine—Anorexia—Doxorubicin—pancreatic cancer	0.000151	0.00118	CcSEcCtD
Thioridazine—Nausea—Docetaxel—pancreatic cancer	0.000151	0.00118	CcSEcCtD
Thioridazine—Decreased appetite—Epirubicin—pancreatic cancer	0.000149	0.00117	CcSEcCtD
Thioridazine—Hypotension—Doxorubicin—pancreatic cancer	0.000148	0.00116	CcSEcCtD
Thioridazine—Constipation—Epirubicin—pancreatic cancer	0.000146	0.00115	CcSEcCtD
Thioridazine—HTR2A—digestive system—pancreatic cancer	0.000145	0.0164	CbGeAlD
Thioridazine—Feeling abnormal—Epirubicin—pancreatic cancer	0.000141	0.0011	CcSEcCtD
Thioridazine—Somnolence—Doxorubicin—pancreatic cancer	0.000141	0.0011	CcSEcCtD
Thioridazine—Decreased appetite—Doxorubicin—pancreatic cancer	0.000138	0.00108	CcSEcCtD
Thioridazine—Constipation—Doxorubicin—pancreatic cancer	0.000136	0.00106	CcSEcCtD
Thioridazine—Body temperature increased—Epirubicin—pancreatic cancer	0.000135	0.00106	CcSEcCtD
Thioridazine—CYP2D6—digestive system—pancreatic cancer	0.000132	0.0149	CbGeAlD
Thioridazine—Feeling abnormal—Doxorubicin—pancreatic cancer	0.000131	0.00102	CcSEcCtD
Thioridazine—Hypersensitivity—Epirubicin—pancreatic cancer	0.000126	0.000988	CcSEcCtD
Thioridazine—Body temperature increased—Doxorubicin—pancreatic cancer	0.000125	0.00098	CcSEcCtD
Thioridazine—Diarrhoea—Epirubicin—pancreatic cancer	0.000117	0.000917	CcSEcCtD
Thioridazine—Hypersensitivity—Doxorubicin—pancreatic cancer	0.000117	0.000914	CcSEcCtD
Thioridazine—Vomiting—Epirubicin—pancreatic cancer	0.000109	0.000852	CcSEcCtD
Thioridazine—Diarrhoea—Doxorubicin—pancreatic cancer	0.000108	0.000849	CcSEcCtD
Thioridazine—Rash—Epirubicin—pancreatic cancer	0.000108	0.000845	CcSEcCtD
Thioridazine—Dermatitis—Epirubicin—pancreatic cancer	0.000108	0.000844	CcSEcCtD
Thioridazine—Headache—Epirubicin—pancreatic cancer	0.000107	0.00084	CcSEcCtD
Thioridazine—Nausea—Epirubicin—pancreatic cancer	0.000102	0.000796	CcSEcCtD
Thioridazine—Vomiting—Doxorubicin—pancreatic cancer	0.000101	0.000789	CcSEcCtD
Thioridazine—Rash—Doxorubicin—pancreatic cancer	9.99e-05	0.000782	CcSEcCtD
Thioridazine—Dermatitis—Doxorubicin—pancreatic cancer	9.99e-05	0.000781	CcSEcCtD
Thioridazine—Headache—Doxorubicin—pancreatic cancer	9.93e-05	0.000777	CcSEcCtD
Thioridazine—Nausea—Doxorubicin—pancreatic cancer	9.42e-05	0.000737	CcSEcCtD
Thioridazine—HTR2C—Signaling Pathways—CTNNB1—pancreatic cancer	7.05e-06	5.04e-05	CbGpPWpGaD
Thioridazine—CYP2C9—Metabolism—APOE—pancreatic cancer	7.02e-06	5.02e-05	CbGpPWpGaD
Thioridazine—DRD2—Signaling Pathways—PIK3CB—pancreatic cancer	7.02e-06	5.02e-05	CbGpPWpGaD
Thioridazine—ADRA1B—Signaling Pathways—CASP3—pancreatic cancer	7e-06	5.01e-05	CbGpPWpGaD
Thioridazine—CHRM2—Signaling by GPCR—PIK3CA—pancreatic cancer	7e-06	5e-05	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling by GPCR—PIK3CA—pancreatic cancer	6.98e-06	4.99e-05	CbGpPWpGaD
Thioridazine—HTR1A—Signaling Pathways—MMP9—pancreatic cancer	6.95e-06	4.97e-05	CbGpPWpGaD
Thioridazine—CYP2C19—Metabolism—PIK3CG—pancreatic cancer	6.95e-06	4.97e-05	CbGpPWpGaD
Thioridazine—HTR2C—Signaling Pathways—MMP9—pancreatic cancer	6.91e-06	4.94e-05	CbGpPWpGaD
Thioridazine—HTR1A—Signaling Pathways—PTEN—pancreatic cancer	6.91e-06	4.94e-05	CbGpPWpGaD
Thioridazine—HTR2A—Signaling Pathways—PIK3CB—pancreatic cancer	6.91e-06	4.94e-05	CbGpPWpGaD
Thioridazine—CYP2E1—Metabolism—PIK3CB—pancreatic cancer	6.9e-06	4.94e-05	CbGpPWpGaD
Thioridazine—HRH1—Signaling Pathways—PIK3CB—pancreatic cancer	6.89e-06	4.93e-05	CbGpPWpGaD
Thioridazine—HTR2C—Signaling Pathways—PTEN—pancreatic cancer	6.87e-06	4.92e-05	CbGpPWpGaD
Thioridazine—CYP2C8—Metabolism—PIK3CD—pancreatic cancer	6.84e-06	4.89e-05	CbGpPWpGaD
Thioridazine—CYP2E1—Metabolism—PTGS2—pancreatic cancer	6.84e-06	4.89e-05	CbGpPWpGaD
Thioridazine—ADRA1B—Signaling Pathways—CCND1—pancreatic cancer	6.82e-06	4.88e-05	CbGpPWpGaD
Thioridazine—CHRM2—Signaling Pathways—PIK3CB—pancreatic cancer	6.78e-06	4.85e-05	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling Pathways—PIK3CB—pancreatic cancer	6.76e-06	4.84e-05	CbGpPWpGaD
Thioridazine—ADRA1B—Signaling Pathways—CTNNB1—pancreatic cancer	6.75e-06	4.83e-05	CbGpPWpGaD
Thioridazine—DRD2—Signaling Pathways—CXCL8—pancreatic cancer	6.75e-06	4.82e-05	CbGpPWpGaD
Thioridazine—HTR1A—Signaling by GPCR—AKT1—pancreatic cancer	6.74e-06	4.82e-05	CbGpPWpGaD
Thioridazine—CYP2C19—Metabolism—PPARG—pancreatic cancer	6.71e-06	4.8e-05	CbGpPWpGaD
Thioridazine—HTR2C—Signaling by GPCR—AKT1—pancreatic cancer	6.71e-06	4.8e-05	CbGpPWpGaD
Thioridazine—DRD2—Signaling by GPCR—HRAS—pancreatic cancer	6.7e-06	4.79e-05	CbGpPWpGaD
Thioridazine—DRD1—Signaling Pathways—MYC—pancreatic cancer	6.68e-06	4.77e-05	CbGpPWpGaD
Thioridazine—DRD1—Signaling Pathways—TGFB1—pancreatic cancer	6.66e-06	4.76e-05	CbGpPWpGaD
Thioridazine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	6.65e-06	4.75e-05	CbGpPWpGaD
Thioridazine—HTR2A—Signaling Pathways—CXCL8—pancreatic cancer	6.64e-06	4.75e-05	CbGpPWpGaD
Thioridazine—HRH1—Signaling Pathways—CXCL8—pancreatic cancer	6.62e-06	4.74e-05	CbGpPWpGaD
Thioridazine—ADRA1B—Signaling Pathways—MMP9—pancreatic cancer	6.62e-06	4.73e-05	CbGpPWpGaD
Thioridazine—HTR2A—Signaling by GPCR—HRAS—pancreatic cancer	6.6e-06	4.72e-05	CbGpPWpGaD
Thioridazine—HTR6—Signaling Pathways—PIK3CA—pancreatic cancer	6.59e-06	4.71e-05	CbGpPWpGaD
Thioridazine—HRH1—Signaling by GPCR—HRAS—pancreatic cancer	6.58e-06	4.71e-05	CbGpPWpGaD
Thioridazine—ADRA1B—Signaling Pathways—PTEN—pancreatic cancer	6.58e-06	4.71e-05	CbGpPWpGaD
Thioridazine—HTR7—Signaling Pathways—PIK3CA—pancreatic cancer	6.58e-06	4.7e-05	CbGpPWpGaD
Thioridazine—DRD1—Signaling Pathways—EGFR—pancreatic cancer	6.53e-06	4.67e-05	CbGpPWpGaD
Thioridazine—CHRM2—Signaling Pathways—CXCL8—pancreatic cancer	6.52e-06	4.66e-05	CbGpPWpGaD
Thioridazine—DRD2—GPCR downstream signaling—AKT1—pancreatic cancer	6.52e-06	4.66e-05	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling Pathways—CXCL8—pancreatic cancer	6.5e-06	4.65e-05	CbGpPWpGaD
Thioridazine—ADRA2A—Metabolism—PTEN—pancreatic cancer	6.49e-06	4.64e-05	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling by GPCR—PIK3CA—pancreatic cancer	6.49e-06	4.64e-05	CbGpPWpGaD
Thioridazine—CHRM2—Signaling by GPCR—HRAS—pancreatic cancer	6.48e-06	4.63e-05	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling by GPCR—HRAS—pancreatic cancer	6.46e-06	4.62e-05	CbGpPWpGaD
Thioridazine—DRD2—Signaling Pathways—CASP3—pancreatic cancer	6.46e-06	4.62e-05	CbGpPWpGaD
Thioridazine—ADRA1B—Signaling by GPCR—AKT1—pancreatic cancer	6.42e-06	4.59e-05	CbGpPWpGaD
Thioridazine—HTR2A—GPCR downstream signaling—AKT1—pancreatic cancer	6.41e-06	4.59e-05	CbGpPWpGaD
Thioridazine—HTR1A—Signaling Pathways—SRC—pancreatic cancer	6.41e-06	4.58e-05	CbGpPWpGaD
Thioridazine—HRH1—GPCR downstream signaling—AKT1—pancreatic cancer	6.4e-06	4.58e-05	CbGpPWpGaD
Thioridazine—CYP2D6—Metabolism—PIK3CG—pancreatic cancer	6.39e-06	4.57e-05	CbGpPWpGaD
Thioridazine—HTR2C—Signaling Pathways—SRC—pancreatic cancer	6.37e-06	4.56e-05	CbGpPWpGaD
Thioridazine—HTR6—Signaling Pathways—TP53—pancreatic cancer	6.37e-06	4.56e-05	CbGpPWpGaD
Thioridazine—HTR7—Signaling Pathways—TP53—pancreatic cancer	6.36e-06	4.55e-05	CbGpPWpGaD
Thioridazine—HTR2A—Signaling Pathways—CASP3—pancreatic cancer	6.35e-06	4.54e-05	CbGpPWpGaD
Thioridazine—HRH1—Signaling Pathways—CASP3—pancreatic cancer	6.34e-06	4.53e-05	CbGpPWpGaD
Thioridazine—CYP2C9—Metabolism—PIK3CG—pancreatic cancer	6.34e-06	4.53e-05	CbGpPWpGaD
Thioridazine—CHRM2—GPCR downstream signaling—AKT1—pancreatic cancer	6.3e-06	4.5e-05	CbGpPWpGaD
Thioridazine—DRD2—Signaling Pathways—CCND1—pancreatic cancer	6.29e-06	4.49e-05	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—PIK3CB—pancreatic cancer	6.28e-06	4.49e-05	CbGpPWpGaD
Thioridazine—ADRA1A—GPCR downstream signaling—AKT1—pancreatic cancer	6.28e-06	4.49e-05	CbGpPWpGaD
Thioridazine—HTR1A—Signaling Pathways—VEGFA—pancreatic cancer	6.24e-06	4.46e-05	CbGpPWpGaD
Thioridazine—CHRM2—Signaling Pathways—CASP3—pancreatic cancer	6.24e-06	4.46e-05	CbGpPWpGaD
Thioridazine—DRD2—Signaling Pathways—CTNNB1—pancreatic cancer	6.22e-06	4.45e-05	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling Pathways—CASP3—pancreatic cancer	6.22e-06	4.45e-05	CbGpPWpGaD
Thioridazine—HTR2C—Signaling Pathways—VEGFA—pancreatic cancer	6.21e-06	4.44e-05	CbGpPWpGaD
Thioridazine—HTR2A—Signaling Pathways—CCND1—pancreatic cancer	6.18e-06	4.42e-05	CbGpPWpGaD
Thioridazine—HTR1A—Signaling Pathways—STAT3—pancreatic cancer	6.18e-06	4.42e-05	CbGpPWpGaD
Thioridazine—HRH1—Signaling Pathways—CCND1—pancreatic cancer	6.17e-06	4.41e-05	CbGpPWpGaD
Thioridazine—DRD1—Signaling Pathways—KRAS—pancreatic cancer	6.17e-06	4.41e-05	CbGpPWpGaD
Thioridazine—CYP2D6—Metabolism—PPARG—pancreatic cancer	6.17e-06	4.41e-05	CbGpPWpGaD
Thioridazine—HTR1A—Signaling Pathways—NRAS—pancreatic cancer	6.16e-06	4.41e-05	CbGpPWpGaD
Thioridazine—HTR2C—Signaling Pathways—STAT3—pancreatic cancer	6.15e-06	4.4e-05	CbGpPWpGaD
Thioridazine—HTR2C—Signaling Pathways—NRAS—pancreatic cancer	6.13e-06	4.39e-05	CbGpPWpGaD
Thioridazine—HTR2A—Signaling Pathways—CTNNB1—pancreatic cancer	6.12e-06	4.38e-05	CbGpPWpGaD
Thioridazine—CYP2C9—Metabolism—PPARG—pancreatic cancer	6.12e-06	4.37e-05	CbGpPWpGaD
Thioridazine—HRH1—Signaling Pathways—CTNNB1—pancreatic cancer	6.11e-06	4.37e-05	CbGpPWpGaD
Thioridazine—CYP2C19—Metabolism—PIK3CD—pancreatic cancer	6.11e-06	4.37e-05	CbGpPWpGaD
Thioridazine—ADRA1B—Signaling Pathways—SRC—pancreatic cancer	6.1e-06	4.36e-05	CbGpPWpGaD
Thioridazine—DRD2—Signaling Pathways—MMP9—pancreatic cancer	6.1e-06	4.36e-05	CbGpPWpGaD
Thioridazine—HTR6—Signaling Pathways—HRAS—pancreatic cancer	6.09e-06	4.36e-05	CbGpPWpGaD
Thioridazine—HTR7—Signaling Pathways—HRAS—pancreatic cancer	6.09e-06	4.35e-05	CbGpPWpGaD
Thioridazine—CHRM2—Signaling Pathways—CCND1—pancreatic cancer	6.07e-06	4.34e-05	CbGpPWpGaD
Thioridazine—DRD2—Signaling Pathways—PTEN—pancreatic cancer	6.07e-06	4.34e-05	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling Pathways—CCND1—pancreatic cancer	6.06e-06	4.33e-05	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—CXCL8—pancreatic cancer	6.04e-06	4.32e-05	CbGpPWpGaD
Thioridazine—CHRM2—Signaling Pathways—CTNNB1—pancreatic cancer	6.01e-06	4.3e-05	CbGpPWpGaD
Thioridazine—HTR2A—Signaling Pathways—MMP9—pancreatic cancer	6e-06	4.29e-05	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling by GPCR—HRAS—pancreatic cancer	6e-06	4.29e-05	CbGpPWpGaD
Thioridazine—CYP1A2—Metabolism—APOE—pancreatic cancer	6e-06	4.29e-05	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling Pathways—CTNNB1—pancreatic cancer	6e-06	4.29e-05	CbGpPWpGaD
Thioridazine—HRH1—Signaling Pathways—MMP9—pancreatic cancer	5.99e-06	4.28e-05	CbGpPWpGaD
Thioridazine—HTR2A—Signaling Pathways—PTEN—pancreatic cancer	5.97e-06	4.27e-05	CbGpPWpGaD
Thioridazine—CYP2C8—Metabolism—PIK3CB—pancreatic cancer	5.97e-06	4.27e-05	CbGpPWpGaD
Thioridazine—CYP2E1—Metabolism—PTEN—pancreatic cancer	5.96e-06	4.26e-05	CbGpPWpGaD
Thioridazine—HRH1—Signaling Pathways—PTEN—pancreatic cancer	5.96e-06	4.26e-05	CbGpPWpGaD
Thioridazine—ADRA1B—Signaling Pathways—VEGFA—pancreatic cancer	5.94e-06	4.25e-05	CbGpPWpGaD
Thioridazine—DRD2—Signaling by GPCR—AKT1—pancreatic cancer	5.92e-06	4.23e-05	CbGpPWpGaD
Thioridazine—CYP2C8—Metabolism—PTGS2—pancreatic cancer	5.91e-06	4.23e-05	CbGpPWpGaD
Thioridazine—CHRM2—Signaling Pathways—MMP9—pancreatic cancer	5.9e-06	4.22e-05	CbGpPWpGaD
Thioridazine—ADRA1B—Signaling Pathways—STAT3—pancreatic cancer	5.89e-06	4.21e-05	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling Pathways—MMP9—pancreatic cancer	5.88e-06	4.2e-05	CbGpPWpGaD
Thioridazine—ADRA1B—Signaling Pathways—NRAS—pancreatic cancer	5.87e-06	4.2e-05	CbGpPWpGaD
Thioridazine—CHRM2—Signaling Pathways—PTEN—pancreatic cancer	5.86e-06	4.19e-05	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling Pathways—PTEN—pancreatic cancer	5.84e-06	4.18e-05	CbGpPWpGaD
Thioridazine—ADRA2A—GPCR downstream signaling—AKT1—pancreatic cancer	5.83e-06	4.17e-05	CbGpPWpGaD
Thioridazine—HTR2A—Signaling by GPCR—AKT1—pancreatic cancer	5.82e-06	4.16e-05	CbGpPWpGaD
Thioridazine—HRH1—Signaling by GPCR—AKT1—pancreatic cancer	5.81e-06	4.16e-05	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—CASP3—pancreatic cancer	5.78e-06	4.13e-05	CbGpPWpGaD
Thioridazine—HTR1A—Signaling Pathways—MYC—pancreatic cancer	5.74e-06	4.11e-05	CbGpPWpGaD
Thioridazine—HTR1A—Signaling Pathways—TGFB1—pancreatic cancer	5.73e-06	4.1e-05	CbGpPWpGaD
Thioridazine—CHRM2—Signaling by GPCR—AKT1—pancreatic cancer	5.72e-06	4.09e-05	CbGpPWpGaD
Thioridazine—HTR2C—Signaling Pathways—MYC—pancreatic cancer	5.71e-06	4.08e-05	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling by GPCR—AKT1—pancreatic cancer	5.7e-06	4.08e-05	CbGpPWpGaD
Thioridazine—HTR2C—Signaling Pathways—TGFB1—pancreatic cancer	5.7e-06	4.07e-05	CbGpPWpGaD
Thioridazine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	5.68e-06	4.06e-05	CbGpPWpGaD
Thioridazine—DRD1—Signaling Pathways—PIK3CA—pancreatic cancer	5.67e-06	4.05e-05	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—CCND1—pancreatic cancer	5.63e-06	4.02e-05	CbGpPWpGaD
Thioridazine—DRD2—Signaling Pathways—SRC—pancreatic cancer	5.63e-06	4.02e-05	CbGpPWpGaD
Thioridazine—CYP2D6—Metabolism—PIK3CD—pancreatic cancer	5.62e-06	4.02e-05	CbGpPWpGaD
Thioridazine—HTR1A—Signaling Pathways—EGFR—pancreatic cancer	5.62e-06	4.02e-05	CbGpPWpGaD
Thioridazine—HTR2C—Signaling Pathways—EGFR—pancreatic cancer	5.59e-06	4e-05	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—CTNNB1—pancreatic cancer	5.57e-06	3.98e-05	CbGpPWpGaD
Thioridazine—CYP2C9—Metabolism—PIK3CD—pancreatic cancer	5.57e-06	3.98e-05	CbGpPWpGaD
Thioridazine—HTR2A—Signaling Pathways—SRC—pancreatic cancer	5.54e-06	3.96e-05	CbGpPWpGaD
Thioridazine—HRH1—Signaling Pathways—SRC—pancreatic cancer	5.52e-06	3.95e-05	CbGpPWpGaD
Thioridazine—DRD1—Signaling Pathways—TP53—pancreatic cancer	5.48e-06	3.92e-05	CbGpPWpGaD
Thioridazine—DRD2—Signaling Pathways—VEGFA—pancreatic cancer	5.48e-06	3.92e-05	CbGpPWpGaD
Thioridazine—ADRA1B—Signaling Pathways—MYC—pancreatic cancer	5.47e-06	3.91e-05	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—MMP9—pancreatic cancer	5.46e-06	3.91e-05	CbGpPWpGaD
Thioridazine—ADRA1B—Signaling Pathways—TGFB1—pancreatic cancer	5.46e-06	3.9e-05	CbGpPWpGaD
Thioridazine—CHRM2—Signaling Pathways—SRC—pancreatic cancer	5.44e-06	3.89e-05	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—PTEN—pancreatic cancer	5.43e-06	3.88e-05	CbGpPWpGaD
Thioridazine—DRD2—Signaling Pathways—STAT3—pancreatic cancer	5.43e-06	3.88e-05	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling Pathways—SRC—pancreatic cancer	5.42e-06	3.88e-05	CbGpPWpGaD
Thioridazine—CYP1A2—Metabolism—PIK3CG—pancreatic cancer	5.41e-06	3.87e-05	CbGpPWpGaD
Thioridazine—DRD2—Signaling Pathways—NRAS—pancreatic cancer	5.41e-06	3.87e-05	CbGpPWpGaD
Thioridazine—HTR2A—Signaling Pathways—VEGFA—pancreatic cancer	5.39e-06	3.86e-05	CbGpPWpGaD
Thioridazine—HRH1—Signaling Pathways—VEGFA—pancreatic cancer	5.38e-06	3.85e-05	CbGpPWpGaD
Thioridazine—HTR6—Signaling Pathways—AKT1—pancreatic cancer	5.38e-06	3.85e-05	CbGpPWpGaD
Thioridazine—HTR7—Signaling Pathways—AKT1—pancreatic cancer	5.37e-06	3.84e-05	CbGpPWpGaD
Thioridazine—ADRA1B—Signaling Pathways—EGFR—pancreatic cancer	5.35e-06	3.82e-05	CbGpPWpGaD
Thioridazine—HTR2A—Signaling Pathways—STAT3—pancreatic cancer	5.34e-06	3.82e-05	CbGpPWpGaD
Thioridazine—HRH1—Signaling Pathways—STAT3—pancreatic cancer	5.33e-06	3.81e-05	CbGpPWpGaD
Thioridazine—HTR2A—Signaling Pathways—NRAS—pancreatic cancer	5.33e-06	3.81e-05	CbGpPWpGaD
Thioridazine—CYP2C19—Metabolism—PIK3CB—pancreatic cancer	5.32e-06	3.81e-05	CbGpPWpGaD
Thioridazine—HRH1—Signaling Pathways—NRAS—pancreatic cancer	5.31e-06	3.8e-05	CbGpPWpGaD
Thioridazine—HTR1A—Signaling Pathways—KRAS—pancreatic cancer	5.31e-06	3.79e-05	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling by GPCR—AKT1—pancreatic cancer	5.3e-06	3.79e-05	CbGpPWpGaD
Thioridazine—CHRM2—Signaling Pathways—VEGFA—pancreatic cancer	5.29e-06	3.79e-05	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling Pathways—VEGFA—pancreatic cancer	5.28e-06	3.78e-05	CbGpPWpGaD
Thioridazine—HTR2C—Signaling Pathways—KRAS—pancreatic cancer	5.28e-06	3.77e-05	CbGpPWpGaD
Thioridazine—CYP2C19—Metabolism—PTGS2—pancreatic cancer	5.28e-06	3.77e-05	CbGpPWpGaD
Thioridazine—DRD1—Signaling Pathways—HRAS—pancreatic cancer	5.24e-06	3.75e-05	CbGpPWpGaD
Thioridazine—CHRM2—Signaling Pathways—STAT3—pancreatic cancer	5.24e-06	3.75e-05	CbGpPWpGaD
Thioridazine—CHRM2—Signaling Pathways—NRAS—pancreatic cancer	5.23e-06	3.74e-05	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling Pathways—STAT3—pancreatic cancer	5.23e-06	3.74e-05	CbGpPWpGaD
Thioridazine—CYP1A2—Metabolism—PPARG—pancreatic cancer	5.23e-06	3.74e-05	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling Pathways—NRAS—pancreatic cancer	5.21e-06	3.73e-05	CbGpPWpGaD
Thioridazine—CYP2C8—Metabolism—PTEN—pancreatic cancer	5.16e-06	3.69e-05	CbGpPWpGaD
Thioridazine—ADRA1B—Signaling Pathways—KRAS—pancreatic cancer	5.05e-06	3.61e-05	CbGpPWpGaD
Thioridazine—DRD2—Signaling Pathways—MYC—pancreatic cancer	5.04e-06	3.61e-05	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—SRC—pancreatic cancer	5.04e-06	3.6e-05	CbGpPWpGaD
Thioridazine—DRD2—Signaling Pathways—TGFB1—pancreatic cancer	5.03e-06	3.6e-05	CbGpPWpGaD
Thioridazine—HTR2A—Signaling Pathways—MYC—pancreatic cancer	4.96e-06	3.55e-05	CbGpPWpGaD
Thioridazine—HRH1—Signaling Pathways—MYC—pancreatic cancer	4.95e-06	3.54e-05	CbGpPWpGaD
Thioridazine—HTR2A—Signaling Pathways—TGFB1—pancreatic cancer	4.95e-06	3.54e-05	CbGpPWpGaD
Thioridazine—HRH1—Signaling Pathways—TGFB1—pancreatic cancer	4.94e-06	3.53e-05	CbGpPWpGaD
Thioridazine—DRD2—Signaling Pathways—EGFR—pancreatic cancer	4.93e-06	3.53e-05	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—VEGFA—pancreatic cancer	4.91e-06	3.51e-05	CbGpPWpGaD
Thioridazine—CYP2D6—Metabolism—PIK3CB—pancreatic cancer	4.9e-06	3.5e-05	CbGpPWpGaD
Thioridazine—HTR1A—Signaling Pathways—PIK3CA—pancreatic cancer	4.87e-06	3.49e-05	CbGpPWpGaD
Thioridazine—CHRM2—Signaling Pathways—MYC—pancreatic cancer	4.87e-06	3.48e-05	CbGpPWpGaD
Thioridazine—CHRM2—Signaling Pathways—TGFB1—pancreatic cancer	4.86e-06	3.47e-05	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling Pathways—MYC—pancreatic cancer	4.86e-06	3.47e-05	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—STAT3—pancreatic cancer	4.86e-06	3.47e-05	CbGpPWpGaD
Thioridazine—CYP2C9—Metabolism—PIK3CB—pancreatic cancer	4.86e-06	3.47e-05	CbGpPWpGaD
Thioridazine—CYP2D6—Metabolism—PTGS2—pancreatic cancer	4.85e-06	3.47e-05	CbGpPWpGaD
Thioridazine—HTR2A—Signaling Pathways—EGFR—pancreatic cancer	4.85e-06	3.47e-05	CbGpPWpGaD
Thioridazine—HTR2C—Signaling Pathways—PIK3CA—pancreatic cancer	4.85e-06	3.47e-05	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling Pathways—TGFB1—pancreatic cancer	4.85e-06	3.46e-05	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—NRAS—pancreatic cancer	4.85e-06	3.46e-05	CbGpPWpGaD
Thioridazine—HRH1—Signaling Pathways—EGFR—pancreatic cancer	4.84e-06	3.46e-05	CbGpPWpGaD
Thioridazine—CYP2C9—Metabolism—PTGS2—pancreatic cancer	4.81e-06	3.44e-05	CbGpPWpGaD
Thioridazine—CHRM2—Signaling Pathways—EGFR—pancreatic cancer	4.76e-06	3.41e-05	CbGpPWpGaD
Thioridazine—CYP1A2—Metabolism—PIK3CD—pancreatic cancer	4.76e-06	3.4e-05	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling Pathways—EGFR—pancreatic cancer	4.75e-06	3.4e-05	CbGpPWpGaD
Thioridazine—HTR1A—Signaling Pathways—TP53—pancreatic cancer	4.72e-06	3.37e-05	CbGpPWpGaD
Thioridazine—HTR2C—Signaling Pathways—TP53—pancreatic cancer	4.69e-06	3.35e-05	CbGpPWpGaD
Thioridazine—DRD2—Signaling Pathways—KRAS—pancreatic cancer	4.66e-06	3.33e-05	CbGpPWpGaD
Thioridazine—ADRA1B—Signaling Pathways—PIK3CA—pancreatic cancer	4.64e-06	3.32e-05	CbGpPWpGaD
Thioridazine—DRD1—Signaling Pathways—AKT1—pancreatic cancer	4.63e-06	3.31e-05	CbGpPWpGaD
Thioridazine—CYP2C19—Metabolism—PTEN—pancreatic cancer	4.6e-06	3.29e-05	CbGpPWpGaD
Thioridazine—HTR2A—Signaling Pathways—KRAS—pancreatic cancer	4.58e-06	3.28e-05	CbGpPWpGaD
Thioridazine—ADRA2A—Metabolism—PIK3CA—pancreatic cancer	4.58e-06	3.28e-05	CbGpPWpGaD
Thioridazine—HRH1—Signaling Pathways—KRAS—pancreatic cancer	4.57e-06	3.27e-05	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—MYC—pancreatic cancer	4.51e-06	3.23e-05	CbGpPWpGaD
Thioridazine—HTR1A—Signaling Pathways—HRAS—pancreatic cancer	4.51e-06	3.22e-05	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—TGFB1—pancreatic cancer	4.5e-06	3.22e-05	CbGpPWpGaD
Thioridazine—CHRM2—Signaling Pathways—KRAS—pancreatic cancer	4.5e-06	3.22e-05	CbGpPWpGaD
Thioridazine—ADRA1B—Signaling Pathways—TP53—pancreatic cancer	4.49e-06	3.21e-05	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling Pathways—KRAS—pancreatic cancer	4.49e-06	3.21e-05	CbGpPWpGaD
Thioridazine—HTR2C—Signaling Pathways—HRAS—pancreatic cancer	4.49e-06	3.21e-05	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—EGFR—pancreatic cancer	4.41e-06	3.16e-05	CbGpPWpGaD
Thioridazine—ADRA1B—Signaling Pathways—HRAS—pancreatic cancer	4.29e-06	3.07e-05	CbGpPWpGaD
Thioridazine—DRD2—Signaling Pathways—PIK3CA—pancreatic cancer	4.28e-06	3.06e-05	CbGpPWpGaD
Thioridazine—CYP2D6—Metabolism—PTEN—pancreatic cancer	4.23e-06	3.03e-05	CbGpPWpGaD
Thioridazine—HTR2A—Signaling Pathways—PIK3CA—pancreatic cancer	4.21e-06	3.01e-05	CbGpPWpGaD
Thioridazine—CYP2E1—Metabolism—PIK3CA—pancreatic cancer	4.21e-06	3.01e-05	CbGpPWpGaD
Thioridazine—HRH1—Signaling Pathways—PIK3CA—pancreatic cancer	4.2e-06	3e-05	CbGpPWpGaD
Thioridazine—CYP2C9—Metabolism—PTEN—pancreatic cancer	4.2e-06	3e-05	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—KRAS—pancreatic cancer	4.17e-06	2.98e-05	CbGpPWpGaD
Thioridazine—CYP1A2—Metabolism—PIK3CB—pancreatic cancer	4.15e-06	2.97e-05	CbGpPWpGaD
Thioridazine—DRD2—Signaling Pathways—TP53—pancreatic cancer	4.14e-06	2.96e-05	CbGpPWpGaD
Thioridazine—CHRM2—Signaling Pathways—PIK3CA—pancreatic cancer	4.13e-06	2.96e-05	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling Pathways—PIK3CA—pancreatic cancer	4.12e-06	2.95e-05	CbGpPWpGaD
Thioridazine—CYP1A2—Metabolism—PTGS2—pancreatic cancer	4.11e-06	2.94e-05	CbGpPWpGaD
Thioridazine—HTR2A—Signaling Pathways—TP53—pancreatic cancer	4.07e-06	2.91e-05	CbGpPWpGaD
Thioridazine—HRH1—Signaling Pathways—TP53—pancreatic cancer	4.07e-06	2.91e-05	CbGpPWpGaD
Thioridazine—CHRM2—Signaling Pathways—TP53—pancreatic cancer	4e-06	2.86e-05	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling Pathways—TP53—pancreatic cancer	3.99e-06	2.85e-05	CbGpPWpGaD
Thioridazine—HTR1A—Signaling Pathways—AKT1—pancreatic cancer	3.98e-06	2.85e-05	CbGpPWpGaD
Thioridazine—HTR2C—Signaling Pathways—AKT1—pancreatic cancer	3.96e-06	2.83e-05	CbGpPWpGaD
Thioridazine—DRD2—Signaling Pathways—HRAS—pancreatic cancer	3.96e-06	2.83e-05	CbGpPWpGaD
Thioridazine—HTR2A—Signaling Pathways—HRAS—pancreatic cancer	3.9e-06	2.79e-05	CbGpPWpGaD
Thioridazine—HRH1—Signaling Pathways—HRAS—pancreatic cancer	3.89e-06	2.78e-05	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—PIK3CA—pancreatic cancer	3.83e-06	2.74e-05	CbGpPWpGaD
Thioridazine—CHRM2—Signaling Pathways—HRAS—pancreatic cancer	3.83e-06	2.74e-05	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling Pathways—HRAS—pancreatic cancer	3.81e-06	2.73e-05	CbGpPWpGaD
Thioridazine—ADRA1B—Signaling Pathways—AKT1—pancreatic cancer	3.79e-06	2.71e-05	CbGpPWpGaD
Thioridazine—ADRA2A—Metabolism—AKT1—pancreatic cancer	3.74e-06	2.68e-05	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—TP53—pancreatic cancer	3.71e-06	2.65e-05	CbGpPWpGaD
Thioridazine—CYP2C8—Metabolism—PIK3CA—pancreatic cancer	3.64e-06	2.6e-05	CbGpPWpGaD
Thioridazine—CYP1A2—Metabolism—PTEN—pancreatic cancer	3.59e-06	2.56e-05	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—HRAS—pancreatic cancer	3.54e-06	2.53e-05	CbGpPWpGaD
Thioridazine—DRD2—Signaling Pathways—AKT1—pancreatic cancer	3.5e-06	2.5e-05	CbGpPWpGaD
Thioridazine—HTR2A—Signaling Pathways—AKT1—pancreatic cancer	3.44e-06	2.46e-05	CbGpPWpGaD
Thioridazine—CYP2E1—Metabolism—AKT1—pancreatic cancer	3.44e-06	2.46e-05	CbGpPWpGaD
Thioridazine—HRH1—Signaling Pathways—AKT1—pancreatic cancer	3.43e-06	2.45e-05	CbGpPWpGaD
Thioridazine—CHRM2—Signaling Pathways—AKT1—pancreatic cancer	3.38e-06	2.42e-05	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling Pathways—AKT1—pancreatic cancer	3.37e-06	2.41e-05	CbGpPWpGaD
Thioridazine—CYP2C19—Metabolism—PIK3CA—pancreatic cancer	3.25e-06	2.32e-05	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—AKT1—pancreatic cancer	3.13e-06	2.24e-05	CbGpPWpGaD
Thioridazine—CYP2D6—Metabolism—PIK3CA—pancreatic cancer	2.99e-06	2.13e-05	CbGpPWpGaD
Thioridazine—CYP2C8—Metabolism—AKT1—pancreatic cancer	2.97e-06	2.12e-05	CbGpPWpGaD
Thioridazine—CYP2C9—Metabolism—PIK3CA—pancreatic cancer	2.96e-06	2.12e-05	CbGpPWpGaD
Thioridazine—CYP2C19—Metabolism—AKT1—pancreatic cancer	2.65e-06	1.9e-05	CbGpPWpGaD
Thioridazine—CYP1A2—Metabolism—PIK3CA—pancreatic cancer	2.53e-06	1.81e-05	CbGpPWpGaD
Thioridazine—CYP2D6—Metabolism—AKT1—pancreatic cancer	2.44e-06	1.74e-05	CbGpPWpGaD
Thioridazine—CYP2C9—Metabolism—AKT1—pancreatic cancer	2.42e-06	1.73e-05	CbGpPWpGaD
Thioridazine—CYP1A2—Metabolism—AKT1—pancreatic cancer	2.07e-06	1.48e-05	CbGpPWpGaD
